• Home

 

 

  • About Us
    • Overview
    • Welcome
    • Vision & Values
    • Community Relations
    • History
    • Officers
    • Board of Directors
    • Customer Relationships
    • ISO Certification
    • Business Development
  • Clinical Markets
    • Overview
    • Cardiovascular
    • Ophthalmology
    • Pharmaceuticals
    • In Vitro Diagnostics
    • Other Clinical Markets
  • Technologies
    • Overview
    • Drug Delivery
    • Surface Modification
  • Investors
    • Investor Overview
    • Officers
    • Corporate Governance
    • Stock Performance
    • Financial Highlights
    • News Releases
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Conference Calls
    • IR Events
    • Presentations
    • Investor Inquiries
  • News & Events
    • Events Calendar
    • News Releases
  • Careers
    • Overview
    • Open Positions
    • Network with SurModics
    • Company Culture
    • Benefits
    • Business Overview
  • Home
  • Contact Us
Advancing diagnostic and therapeutic applications.
  • Cardiovascular
  • Ophthalmology
  • Pharmaceuticals
  • In Vitro Diagnostics
  • Other Clinical Markets
Enabling the performance and enhancing the functionality of medical devices, drugs, and diagnostics.
  • Drug Delivery
  • Surface Modification


Recent News

SurModics Completes Sale of Pharmaceutical Assets

SurModics Announces Agreement to Sell Pharmaceutical Assets

SurModics Reports Third Quarter 2011 Results

SurModics Introduces a New In Vitro Diagnostics
Product - SurModics® Assay Diluent (Protein-Free)

 

 

Privacy Policy | Terms of Use | © 2011 SurModics, Inc. All Rights Reserved